A (synthetic) lethal weapon for cancer

Research output: Contribution to journalArticlepeer-review

Abstract

ROS1 inhibition in E-cadherin–decient tumors leads to synthetic lethality, which could be exploited for the selective treatment of breast cancer patients.

Original languageEnglish
Article numberY
JournalScience Translational Medicine
Volume10
Issue number437
DOIs
StatePublished - 18 Apr 2018

Fingerprint

Dive into the research topics of 'A (synthetic) lethal weapon for cancer'. Together they form a unique fingerprint.

Cite this